McMaster University

GOLDEN STATE FOODS PROMOTES MARIANA MANOLE TO SENIOR VICE PRESIDENT, GLOBAL FSQR AND APPOINTMENTS STEVE ROSS AS SENIOR VICE PRESIDENT, OPERATIONS, LIQUID PRODUCTS OF NORTH AMERICA

Retrieved on: 
화요일, 4월 30, 2024
Food safety, GSF, Safety, Wayne Farms, Manole, Regulation, McMaster University, Golden State Foods, Cargill, Regulatory affairs, Golden, TreeHouse Foods, Management

A GSF associate since 2016, she has expertly guided FSQR for all GSF global manufacturing facilities and its growing team of FSQR professionals as group vice president, global FSQR over the past three years.

Key Points: 
  • A GSF associate since 2016, she has expertly guided FSQR for all GSF global manufacturing facilities and its growing team of FSQR professionals as group vice president, global FSQR over the past three years.
  • In her prior GSF roles as group vice president, FSQR – global liquid products and as senior director, quality systems, Manole led LPNA's comprehensive, rapid transformation of all FSQR systems to best-in-class industry status.
  • In his new Conyers, Georgia-based role, Ross will provide leadership and direction to all liquid products operation activities.
  • "We are incredibly excited to welcome Steve and his family to Liquid Products North America and Golden State Foods," said Justin Vannoy, GSF corporate senior vice president and president, LPNA.

Colossal Announces Expansion of Ancient DNA Academic Research Projects with $7.5M in New Investments, and Issues Call to Researchers

Retrieved on: 
월요일, 4월 15, 2024
University, Climate Change, Education, Technology, Health, Other Science, Other Technology, Research, Genetics, Environment, Science, Stockholm University, Investment, CRISPR, Biochemistry, AI, Mammal, Partnership, Life, Love, Mastodon, Genome, Knowledge, Gene, Edelman Fossil Park, Animal, Plant, Biology, Rowan University, Bird, Climate change, DNA, University of Alaska system, Multimedia, Student, Howard Hughes Medical Institute, Genomics, Assistant professor, HUB, McMaster University, Mammoth, University of Copenhagen, Fossil, UC, Hunting

This involves implementing over $7.5M in newly committed funding to Colossal academic partners in 2024, onboarding more ancient DNA researchers, growing a larger network of ancient DNA university partners, and deploying a technology HUB for ancient DNA research.

Key Points: 
  • This involves implementing over $7.5M in newly committed funding to Colossal academic partners in 2024, onboarding more ancient DNA researchers, growing a larger network of ancient DNA university partners, and deploying a technology HUB for ancient DNA research.
  • We believe that to support a biodiverse future, we must facilitate ancient DNA research across the world.
  • Colossal will also continue to establish new partnerships with research teams around the world that are doing groundbreaking ancient DNA science.
  • If you are an ancient DNA researcher interested in joining Colossal’s upcoming ancient DNA technology HUB, please reach out [email protected] .

Seed Health Appoints Microbiome Pioneer Zain Kassam, M.D., M.P.H., as Chief Medical Officer

Retrieved on: 
수요일, 4월 24, 2024
Western University, Harvard University, Nature Biotechnology, Public health, Chairperson, Abstract, Health, McMaster University, OpenBiome, FMT, Janssen, IPO, Therapy, Science, Ecology, Alumni, Internal medicine, Bacillota, Longevity, Growth, MIT, Medical device

BOSTON, April 24, 2024 /PRNewswire/ -- Seed Health, a microbiome science company, today announced the appointment of Zain Kassam, M.D., M.P.H., as Chief Medical Officer. An award-winning physician-scientist, Dr. Kassam has played a pivotal role in the advancement of microbiome science for over a decade. His extensive body of work includes over 200 peer-reviewed publications and abstracts, including in The New England Journal of Medicine, Nature Biotechnology, and Gastroenterology, and co-authoring international clinical practice guidelines. He has championed more than 30 Phase I-III clinical trials with top-tier academic institutions across multiple therapeutic areas. As Chief Medical Officer, Dr. Kassam will collaborate with Chief Scientific Officer, Dirk Gevers, Ph.D., to oversee Seed Health's R&D portfolio. He will expand the company's gut microbiome program and guide upcoming launches in the vaginal and skin microbiome sectors, as well as in brain health, metabolic health, and longevity.

Key Points: 
  • Dr. Kassam will lead Seed Health's clinical research and medical affairs, driving the
    BOSTON, April 24, 2024 /PRNewswire/ -- Seed Health , a microbiome science company, today announced the appointment of Zain Kassam, M.D., M.P.H., as Chief Medical Officer.
  • As Chief Medical Officer, Dr. Kassam will collaborate with Chief Scientific Officer, Dirk Gevers, Ph.D., to oversee Seed Health's R&D portfolio.
  • He will expand the company's gut microbiome program and guide upcoming launches in the vaginal and skin microbiome sectors, as well as in brain health, metabolic health, and longevity.
  • Before joining Seed Health, Dr. Kassam co-founded and was Chief Medical Officer at two foundational microbiome therapeutics companies, OpenBiome and Finch Therapeutics.

Pfizer Canada and McMaster University to foster health equity in vaccine science

Retrieved on: 
화요일, 4월 23, 2024
Nexus, Equity, Health equity, Safety, Policy, Infection, McMaster University, Partnership, Research, Vaccine, McMaster, Student, Pharmaceutical industry

Kirkland, QC and Hamilton, ON, April 23, 2024 /CNW/ - During National Immunization Awareness Week, Pfizer Canada and McMaster University are proud to announce a significant project aimed at addressing critical gaps in health equity in the development and delivery of vaccines.

Key Points: 
  • Kirkland, QC and Hamilton, ON, April 23, 2024 /CNW/ - During National Immunization Awareness Week, Pfizer Canada and McMaster University are proud to announce a significant project aimed at addressing critical gaps in health equity in the development and delivery of vaccines.
  • Recognizing these challenges, Pfizer is proud to support McMaster University's endeavour to support inclusive excellence in vaccine development and delivery.
  • "This grant from Pfizer Canada underscores our shared commitment to advancing health equity," stated Matthew Miller, Executive Director of Global Nexus at McMaster University.
  • This partnership between Pfizer and McMaster University exemplifies a shared vision for a more equitable and resilient healthcare future.

Aqtual Announces Appointment of Medical, Translational Research and Data Integrity Executives

Retrieved on: 
화요일, 4월 16, 2024
Doctor of Philosophy, Conditional sentence, Cancer, Gilead Sciences, Public health, Blood, Simon Fraser University, Virology, Research, McMaster University, University of California, Davis, Data integrity, Medicine, Molecular biology, Catalog, Disease, Imperial College London, Joint, DNA, Therapy, Public, Patient, GRAIL, MPH, Rheumatoid arthritis, Physician, Translational research, Data analysis, UC, Pharmaceutical industry

HAYWARD, Calif., April 16, 2024 /PRNewswire/ -- Aqtual, Inc., a precision medicine company using its novel cell-free DNA platform to develop products for chronic diseases and oncology, today announced it has expanded its team to support the development of its molecular diagnostic test for rheumatoid arthritis (RA) therapy selection and its partnering efforts with companies across the pharma and biotech landscape. Signe Fransen has joined as Vice President of Scientific and Medical Affairs, Maggie Louie, Ph.D., has been appointed by Aqtual as Vice President of Translational Research and Strategic Partnerships, and Jason Carlson, MPH, has been brought on as Vice President of Data Integrity and GxP Systems.

Key Points: 
  • Signe Fransen has joined as Vice President of Scientific and Medical Affairs, Maggie Louie, Ph.D., has been appointed by Aqtual as Vice President of Translational Research and Strategic Partnerships, and Jason Carlson, MPH, has been brought on as Vice President of Data Integrity and GxP Systems.
  • We're excited to welcome Signe, Maggie, and Jason to the team to continue this momentum," said Diana Abdueva, Ph.D., co-founder and CEO of Aqtual.
  • Before her appointment at Aqtual, Maggie served as the Vice President of Research at Earli, where she led research initiatives focused on developing a novel synthetic biomarker platform for cancer diagnostics and therapeutics.
  • Mr. Carlson has decades of experience leading cross-functional teams to sustain data integrity, quality, and compliance throughout the product life cycle.

Theragent Expands Leadership Team with Weifeng "Frank" Zhang as Senior Vice President of Operations

Retrieved on: 
목요일, 4월 11, 2024
Plasmid, Pharma, McMaster University, MD, Doctor of Philosophy, CDMO, Senior, Bristol Myers Squibb, Patient, Master of Engineering, Health, GMP, Nursing

ARCADIA, Calif., April 11, 2024 /PRNewswire/ -- Theragent Inc., a comprehensive CDMO focused on advancing next-generation cell- and tissue-based therapies, is proud to welcome Weifeng "Frank" Zhang as Senior Vice President of Operations.

Key Points: 
  • ARCADIA, Calif., April 11, 2024 /PRNewswire/ -- Theragent Inc., a comprehensive CDMO focused on advancing next-generation cell- and tissue-based therapies, is proud to welcome Weifeng "Frank" Zhang as Senior Vice President of Operations.
  • Mr. Zhang, joining the team in March of 2024, brings over 25 years of biotech industry experience to the table.
  • Mr. Zhang joins Theragent from his most recent position as Vice President of Manufacturing at Tanvex Biopharma.
  • "I am very honored to join the accomplished leadership team at Theragent and look forward to working with my new colleagues," said Mr. Zhang.

As Canadians struggle to make ends meet, Coast Capital introduces first-of-its-kind account that aims to help people earn more

Retrieved on: 
수요일, 4월 3, 2024
Microsoft, Organization, Motivation, University, University of Alberta, Partnership, Coffee, Education, McMaster University, Intuit, Identity theft, Omnibus, Bank

An Omnibus commissioned by Coast Capital further demonstrates the seemingly impossible financial situation many are facing.

Key Points: 
  • An Omnibus commissioned by Coast Capital further demonstrates the seemingly impossible financial situation many are facing.
  • The study found:
    72 per cent of Canadians do not believe that better budgeting or increased savings alone would improve their situation.
  • 48 per cent believe that obtaining additional education or skills training would help them increase their current income.
  • Maureen Young, Vice President, Social Purpose, Coast Capital, added, “There is a tremendous alignment in values between Coast Capital and Coursera, with our respective missions and purpose going hand-in-hand.

WorldQuant Commences 2024 International Quant Championship

Retrieved on: 
화요일, 3월 19, 2024
Software, Asset Management, Consulting, Artificial Intelligence, Data Management, Professional Services, Technology, Other Technology, Algorithm, University, Data science, Environment, IQC, BRAIN, Knowledge, WorldQuant, Research, AI, McMaster University, Student, Machine learning, Multimedia, Consultant

WorldQuant, a global quantitative asset management firm, today announced the launch of its flagship International Quant Championship (IQC) for 2024, a three-stage, team-based competition engaging students, academia and professionals from around the globe.

Key Points: 
  • WorldQuant, a global quantitative asset management firm, today announced the launch of its flagship International Quant Championship (IQC) for 2024, a three-stage, team-based competition engaging students, academia and professionals from around the globe.
  • View the full release here: https://www.businesswire.com/news/home/20240319558098/en/
    The 2024 IQC, which takes place on WorldQuant’s BRAIN platform, builds on existing competitions hosted by WorldQuant and encourages talent from eligible regions and across experience levels to participate.
  • More than 60 past BRAIN consultants have subsequently become full-time employees at WorldQuant since inception of the platform.
  • 1 WorldQuant defines “Alphas” as mathematical models that seek to predict the future price movements of various financial instruments.

HeadaTerm 2: The Most Affordable FDA Cleared Innovative OTC Anti-Migraine Device

Retrieved on: 
화요일, 4월 2, 2024
Annals of Emergency Medicine, Veteran, Headache (journal), Headache, Patient, American Journal, Emergency medicine, McMaster University, University, Software, Migraine, OTC, Ohio State University, Multimedia, University of Toronto, FDA, Food, Medical device

Using neuromodulation technology, HeadaTerm 2 releases targeted electrical impulses to increase pain tolerance of its users.

Key Points: 
  • Using neuromodulation technology, HeadaTerm 2 releases targeted electrical impulses to increase pain tolerance of its users.
  • HeadaTerm 2 is a testament of WAT Medical's continued commitment to providing safe, effective, and user-friendly innovative medical devices at the most competitive price.
  • It provided an affordable solution to a debilitating condition that affects nearly 40 million people in the U.S. HeadaTerm 2 is a rechargeable device that features adjustable intensity setting and will be the most affordable device of its kind.
  • HeadaTerm 2 will appear at the 66th Annual Scientific Meeting in June 2024 hosted by American Headache Society.

JDRF Proudly Announces the Appointment of New International Board of Directors Vice Chair

Retrieved on: 
수요일, 3월 13, 2024
Royal Bank of Canada, Partnership, Royal Bank, T1D, Research, Parent, McMaster University, JDRF, International Board, Management

NEW YORK and TORONTO, March 13, 2024 /PRNewswire/ -- JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, today announced the appointment of Matt Varey as the new vice chair of the non-profit's International Board of Directors. Matt, of Oakville, Ontario, is the first Canadian and first person from outside of the United States to hold the vice chair position. He is a senior executive at Royal Bank of Canada, the country's largest financial institution, where he is responsible for more than 4,500 Canada-based employees who manage personal investments, mortgage financing, and group benefits totaling more than $100 billion annually.  

Key Points: 
  • "We are delighted that Matt is taking on the role of vice chair of JDRF's International Board of Directors.
  • In addition to his work on JDRF's International Board of Directors, Matt serves on the board of JDRF Canada.
  • "I have been a JDRF volunteer for more than 20 years and am honored to step into the role of vice chair of JDRF's International Board of Directors", said Matt Varey.
  • Varey will be joined in his term of board leadership by Lisa Fishbone Wallack , the newly appointed chair of JDRF's International Board of Directors.